PF 05175157

CAS : 1301214-47-0

Ref. 3D-BCC21447

Informations sur le produit

• Nom: PF 05175157
• Marque: Biosynth
• Description: PF 05175157 is a potent small molecule, orally active inhibitor of fatty acid synthase (FAS) that causes hepatocyte steatosis in vitro and in vivo. PF 05175157 is also an inhibitor of the enzyme stearoyl-CoA desaturase 1 (SCD1), which converts saturated to monounsaturated fatty acids. The compound has been shown to reduce liver and body weight gain in mice fed a high-fat diet, as well as to improve dyslipidemia and hepatic steatosis. PF 05175157 has been evaluated clinically for the treatment of obesity, type 2 diabetes mellitus, and nonalcoholic fatty liver disease. PF 05175157 was granted orphan drug designation for the treatment of pediatric chronic kidney disease by the FDA on June 6, 2015.

Propriétés chimiques

• Masse moléculaire: 405.49 g/mol
• Formule: C₂₃H₂₇N₅O₂
• Degré de pureté: Min. 95%